Press Releases :: Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals to Present at the Emerging Growth Conference on January 25, 2023

Jan 16, 2023

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update

Nov 14, 2022

Acurx Pharmaceuticals, Inc. to Discuss 2022 Third Quarter Financial Results on November 14, 2022 Conference Call and Provide Business Update

Nov 1, 2022

Acurx Announces Scientific Oral and Poster Presented at IDWeek 2022

Oct 26, 2022

Acurx Announces Scientific Oral and Poster Presentations at IDWeek

Oct 17, 2022

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides Business Update

Aug 15, 2022

Acurx Pharmaceuticals, Inc. to Discuss 2022 Second Quarter Financial Results on August 16, 2022 Conference Call and Provide Business Update

Aug 4, 2022

Acurx Announces New Data Presentations from Ongoing Ph2 Clinical Trial Program of Ibezapolstat for CDI at the 16th Biennial Congress of the Anaerobe Society of America

Aug 2, 2022

Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering

Jul 25, 2022

Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update

May 11, 2022